Esra Meltem Kayahan ULU, Elif KARADELİ, Fuldem Yıldırım DÖNMEZ, Erdem ALTUN, Elif DURUKAN, Nilgün ERKEK

İndirekt Hiperbilirubinemili Hastalarda Kranial Manyetik Rezonans Görüntüleme Bulguları

Amaç: İndirekt hiperbiluribinemili hastalarda manyetik rezonans görüntüleme (MRG) değişikliklerinin sıklığını tanımlamak. Yöntem: Biz indirek hiperbiluribinemili 18 yenidoğanın MRG bulgularını sunduk. Üç grup arasındaki biokimyasal, klinik ve görüntülemedeki farkları istatistiksel olarak değerlendirdik. Bulgular: Pik bilirubin seviyeleri 5 yenidoğanda (grup 1) 20- 24 mg/dl, 6 yenidoğanda (grup 2) 25- 29 mg/dl ve 7 yenidoğanda (grup 3) 30 mg/dl ve daha yüksekti. Üç grup arasında hastaların MRG bulguları ve nörolojik bulguları arasında istatistiksel olarak önemli fark vardı. Sonuç: Biz kernikteruslu hastalarda MRG değişiklikleri bulduk. Nörolojik muayeneleri normal olmasına rağmen hiperbilirubinemili hastalarda öncelikle T1A görüntülerde değişiklikler saptadık. Beyinde bilirubinin toksik etkilerinin anlaşabilmesi için klinik takiple birlikte büyük çalışmalar gerekmektedir.

Anahtar Kelimeler:

Manyetik Rezonans Görüntüleme, Kernikterus, Neonatal Hiperbiluribinemi

Cranial Magnetic Resonance Imaging Findings in Patients with Indirect Hyperbilirubinemia

Abstract Purpose: To describe the magnetic resonance imaging (MRI) changes in the patients with indirect hyperbilirubinemia. Methods: MRI findings of eighteen neonates with indirect hyperbilirubinemia were reported by us. The differences in imaging, clinical and biochemical data between three groups were evaluated statistically. Results: Peak bilirubin levels were between 20 and 24 mg per deciliter in 5 of the newborns (group 1), 25 and 29 mg per deciliter in 6 of the newborns (group 2) and 30 mg per deciliter or more in 7 newborns (group 3). There was statistically significant difference between the neurological findings and MRI findings of the patients between three groups. Conclusion: We always demonstrated MRI changes in the patients with kernicterus. Firstly, T1 weighted changes were described in patients with hyperbilirubinemia despite normal neurological examinations. Larger studies with clinical follow up are needed for further understanding of toxic effect of bilirubin in brain. Key words: Özet

Keywords:

magnetic resonance imaging, kernicterus, neonatal hyperbilirubinemia,

PDF

___

Coskun A, Yikilmaz A, Kumandas S, Karahan OI, Akcakus M, Manav A. Hyperintense globus pallidus on T1-weighted MR imaging in acute kernicterus: is it common or rare? Eur Radiol. 2005;15:1263-1267.
Shah Z, Chawla A, Patkar D, Pungaonkar S. MRI in kernicterus. Australasian Radiology 2003;47:55-57.
Sugama S, Soeda A, Eto Y. Magnetic resonance imaging in three children with kernicterus. Pediatric Radiology. 2001;25(4):328-331.
Ip S, Chung M, Kulig J, O'Brien R, Sege R, Glicken S, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;114:e130-e153.
Penn AA, Enzmann DR, Hahn JS, Stevenson DK. Kernicterus in a full term infant. Pediatrics. 1994; 93:1003-1006
Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics. 2001;107:1075-1080
Katar S, Akay HO, Taskesen M, Devecioglu C. Clinical and cranial magnetic resonance imaging (MRI) findings of 21 patients with serious hyperbilirubinemia. J Child Neurol. 2008; 23:415-417
Govaert P, Lequin M, Swarte R, Robben S, De Coo R, Weisglas-Kuperus N, et al. Changes in globus pallidus with (pre) term kernicterus. Pediatrics. 2003; 112:1256-1263
Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol. 2003; 29(5):410-421
Schmorl G. Zur Kenntnis des ikterus neonaturum, insbesondere der dabei auftretetenden gehirnveranderungen. Vehr Dtsch Ges Pathol. 1904; 6:109-15
Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol. 2003; 29:410-421.
Yokochi K. Magnetic resonance imaging in children with kernicterus. Acta pediatr. 1995;84:937-939.
Diamond I, Schmid R. Oxidative phosphporylation in experimental bilirubin encephalopathy. Science. 1967; 155(767):1288-9.
Oakden WK, Moore AM, Blaser S, Noseworthy. 1H MR spectroscopik characteristics of kernicterus: a possible metabolic signature. AJNR Am J Neuroradiol. 2005; 26:1571-1574.
Cordoba J, Sanpedro F, Alonso J, Rovira A. 1H magnetic resonance in the study of hepatic encephalopathy in humans. Metab Brain Dis. 2002; 17:415-429.